keyword
https://read.qxmd.com/read/38634131/cannabinoid-receptor-type-1-activation-causes-a-water-diuresis-by-inducing-an-acute-central-diabetes-insipidus-in-mice
#1
JOURNAL ARTICLE
Joshua L Rein, Ken Mackie, Thomas R Kleyman, Lisa M Satlin
Cannabis and synthetic cannabinoid consumption is increasing worldwide. Cannabis contains numerous phytocannabinoids that act on the G-protein-coupled cannabinoid receptors type 1 (CB1R) and type 2 (CB2R) expressed throughout the body, including the kidney. Essentially every organ, including the kidney, produces endocannabinoids (ECs), endogenous ligands to these receptors. Cannabinoids acutely increase urine output in rodents and humans, thus potentially influencing total-body water and electrolyte homeostasis...
April 18, 2024: American Journal of Physiology. Renal Physiology
https://read.qxmd.com/read/38611847/hemp-seed-oil-inhibits-the-adipogenicity-of-the-differentiation-induced-human-mesenchymal-stem-cells-through-suppressing-the-cannabinoid-type-1-cb1
#2
JOURNAL ARTICLE
Albatul S Almousa, Pandurangan Subash-Babu, Ibrahim O Alanazi, Ali A Alshatwi, Huda Alkhalaf, Eman Bahattab, Atheer Alsiyah, Mohammad Alzahrani
Central and peripheral mechanisms of the endocannabinoid system (ECS) favor energy intake and storage. The ECS, especially cannabidiol (CBD) receptors, controls adipocyte differentiation (hyperplasia) and lipid accumulation (hypertrophy) in adipose tissue. In white adipose tissue, cannabidiol receptor 1 (CB1) stimulation increases lipogenesis and inhibits lipolysis; in brown adipose tissue, it decreases mitochondrial thermogenesis and biogenesis. This study compared the availability of phytocannabinoids [CBD and Δ9-tetrahydrocannabinol (THC)] and polyunsaturated fatty acids [omega 3 (ω3) and omega 6 (ω6)] in different hemp seed oils (HSO)...
March 31, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38601151/cannabidiol-exerts-multitarget-immunomodulatory-effects-on-pbmcs-from-individuals-with-psoriasis-vulgaris
#3
JOURNAL ARTICLE
Cristina Pagano, Elena Ciaglia, Laura Coppola, Valentina Lopardo, Annunziata Raimondo, Monfrecola Giuseppe, Serena Lembo, Chiara Laezza, Maurizio Bifulco
INTRODUCTION: The involvement of endocannabinoid system (ECS) in the inflammatory cascade, and the ability of phytocannabinoids, endocannabinoids and their synthetic analogues to modulate it has become an interesting research area for new therapeutic approaches in inflammatory skin diseases. Cannabidiol (CBD) appears to be the most promising among phytocannabinoids, due to the lack of psychotropic effects and low toxicity profile. Its anti-inflammatory action has been highlighted in different preclinical models, ranging from experimental colitis to arthritis and neuroinflammation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38597712/synthesis-and-functional-evaluation-of-synthetic-cannabinoid-receptor-agonists-related-to-adb-hexinaca
#4
JOURNAL ARTICLE
Eric Sparkes, Axelle Timmerman, Jack W Markham, Rochelle Boyd, Rebecca Gordon, Katelyn A Walker, Richard C Kevin, David E Hibbs, Samuel D Banister, Elizabeth A Cairns, Christophe Stove, Adam Ametovski
ADB-HEXINACA has been recently reported as a synthetic cannabinoid receptor agonist (SCRA), one of the largest classes of new psychoactive substances (NPSs). This compound marks the entry of the n -hexyl tail group into the SCRA landscape, which has continued in the market with recent, newly detected SCRAs. As such, a proactive characterization campaign was undertaken, including the synthesis, characterization, and pharmacological evaluation of ADB-HEXINACA and a library of 41 closely related analogues. Two in vitro functional assays were employed to assess activity at CB1 and CB2 cannabinoid receptors, measuring Gβγ -coupled agonism through a fluorescence-based membrane potential assay (MPA) and β-arrestin 2 (βarr2) recruitment via a live cell-based nanoluciferase complementation reporter assay...
April 10, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38590923/brodifacoum-contamination-of-synthetic-cannabinoid-causing-unexplained-coagulopathy-in-multiple-trauma-a-case-report
#5
Anthony V Thomas, Mackenzie L Johnson, Anna M Tincher, Saniya Zackariya, Hassaan Khan, Uzma Rizvi, Scott G Thomas, Timothy W Noveroske, Daniel H Fulkerson, Ernest E Moore, Mark M Walsh
An 18-year-old female presented to the emergency department after a motor vehicle collision. Initial imaging revealed a liver laceration. Subsequent labs showed significantly elevated prothrombin time, international normalized ratio, and activated partial thromboplastin time. Thromboelastography demonstrated a flatline tracing. The patient denied use of anticoagulation but admitted to synthetic cannabinoid use. It was believed the patient had taken synthetic cannabinoid contaminated by brodifacoum. She was therefore given prothrombin complex concentrate and vitamin K with blood products...
June 2024: Trauma Case Reports
https://read.qxmd.com/read/38586024/rationalizing-diverse-binding-mechanisms-to-the-same-protein-fold-insights-for-ligand-recognition-and-biosensor-design
#6
Alison C Leonard, Anika J Friedman, Rachel Chayer, Brian M Petersen, Joel Kaar, Michael R Shirts, Timothy A Whitehead
The engineering of novel protein-ligand binding interactions, particularly for complex drug-like molecules, is an unsolved problem which could enable many practical applications of protein biosensors. In this work, we analyzed two engineer ed biosensors, derived from the plant hormone sensor PYR1, to recognize either the agrochemical mandipropamid or the synthetic cannabinoid WIN55,212-2. Using a combination of quantitative deep mutational scanning experiments and molecular dynamics simulations, we demonstrated that mutations at common positions can promote protein-ligand shape complementarity and revealed prominent differences in the electrostatic networks needed to complement diverse ligands...
March 29, 2024: bioRxiv
https://read.qxmd.com/read/38584344/plasma-drug-screening-using-paper-spray-mass-spectrometry-with-integrated-solid-phase-extraction
#7
JOURNAL ARTICLE
Hannah Zimmerman-Federle, Greta Ren, Sarah Dowling, Cassandra Warren, Daniel Rusyniak, Robert Avera, Nicholas E Manicke
Drug overdoses have risen dramatically in recent years. We developed a simple nontargeted method using a disposable paper spray cartridge with an integrated solid phase extraction column. This method was used to screen for ~160 fentanyl analogs, synthetic cannabinoids, other synthetic drugs, and traditional drugs of abuse in over 300 authentic overdose samples collected at emergency departments in Indianapolis. A solid phase extraction step was implemented on the paper spray cartridge to enable subnanograms per milliliter synthetic drugs screening in plasma...
April 7, 2024: Drug Testing and Analysis
https://read.qxmd.com/read/38581662/quantitation-of-hexahydrocannabinol-hhc-and-metabolites-in-blood-from-duid-cases
#8
JOURNAL ARTICLE
Robert Kronstrand, Markus Roman, Henrik Green, Michael T Truver
Hexahydrocannabinol (HHC) was first reported in the EU in May 2022. HHC has three chiral carbon atoms, but only (6aR,9R,10aR)-HHC (9R-HHC) and (6aR,9S,10aR)-HHC (9S-HHC) have been encountered in HHC products. The goal of this study was to develop and validate a method for the quantitative analysis of 9R-HHC, 9S-HHC, 11-OH-9R-HHC, 9R-HHC-COOH, 9S-HHC-COOH, and 8-OH-9R-HHC. In addition, an objective was to investigate the immunochemical cross reactivity. Blood samples from DUID-cases screened positive for cannabis using ELISA and confirmed negative for tetrahydrocannabinol (THC), 11-hydroxy-THC, and THC-COOH were reanalyzed with a newly validated HHC method to investigate the presence of HHC and metabolites...
April 6, 2024: Journal of Analytical Toxicology
https://read.qxmd.com/read/38568147/insights-into-primary-care-physicians-detection-intervention-and-management-of-patients-with-substance-use-disorders-in-egypt
#9
JOURNAL ARTICLE
Safaa M El-Zoghby, Reda Madroumi, Stephanie Kewley, Marie Claire Van Hout
Egypt is experiencing an increasing drug problem (cannabis, heroin, amphetamines, pharmaceutical opioids, synthetic cannabinoids). Whilst harm reduction and addiction treatment are provided by government and non-governmental organizations in Egypt, very little is known about physicians experience of handling patient substance use and substance use disorder (SUD) in primary care. A cross-sectional national study of 392 Egyptian Family Physicians (FPs) & General Practitioners (GPs) explored their knowledge, attitude and professional practice regarding management of SUD in primary care, as a first step toward identifying professional development support needs and informing general practice...
April 3, 2024: Journal of Ethnicity in Substance Abuse
https://read.qxmd.com/read/38561104/pharmacological-evaluation-of-new-generation-oxizid-synthetic-cannabinoid-receptor-agonists
#10
JOURNAL ARTICLE
Monica Patel, Xiaoxi Zheng, Luli R Akinfiresoye, Cassandra Prioleau, Teneille D Walker, Michelle Glass, Julie A Marusich
Synthetic cannabinoid receptor agonists (SCRAs) remain one the largest classes of new psychoactive substances, and are increasingly associated with severe adverse effects and death compared to the phytocannabinoid Δ9 -tetrahydrocannabinol (THC). In the attempt to circumvent the rapid emergence of novel SCRAs, several nations have implemented 'generic' legislations, or 'class-wide' bans based on common structural scaffolds. However, this has only encouraged the incorporation of new chemical entities, including distinct core and linker structures, for which there is a dearth of pharmacological data...
March 30, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38558988/cb-1-cannabinoid-receptor-agonists-induce-acute-respiratory-depression-in-awake-mice
#11
Joshua Watkins, Petra Aradi, Rachel Hahn, Istvan Katona, Ken Mackie, Alexandros Makriyannis, Andrea G Hohmann
Recreational use of synthetic cannabinoid agonists (i.e., "Spice" compounds) that target the Cannabinoid Type 1 receptor (CB 1 ) can cause respiratory depression in humans. However, Δ 9 -tetrahydrocannabinol (THC), the major psychoactive phytocannabinoid in cannabis, is not traditionally thought to interact with CNS control of respiration, based largely upon sparse labeling of CB1 receptors in the medulla and few reports of clinically significant respiratory depression following cannabis overdose. The respiratory effects of CB 1 agonists have rarely been studied in vivo , suggesting that additional inquiry is required to reconcile the conflict between conventional wisdom and human data...
March 13, 2024: bioRxiv
https://read.qxmd.com/read/38555505/nutrition-endocannabinoids-and-the-use-of-cannabis-an-overview-for-the-nutrition-clinician
#12
REVIEW
Lindsey Russell, Kayla Condo, Tiffany DeFlorville
The endocannabinoid system (ECs) is composed of multiple signaling compounds and receptors within the central and peripheral nervous system along with various organs, including the gut, liver, and skeletal muscle. The ECs has been implicated in metabolism, gut motility, and eating behaviors. The ECs is altered in disease states such as obesity. Recent studies have clarified the role of the gut microbiome and nutrition on the ECs. Exogenous cannabinoid (CB) use, either organic or synthetic, stimulates the ECs through CB1 and CB2 receptors...
March 30, 2024: Nutrition in Clinical Practice
https://read.qxmd.com/read/38548662/-spice-use-motivations-experiences-and-repercussions-among-veterans-of-the-united-states-armed-forces
#13
JOURNAL ARTICLE
John Stogner, Julie Marie Baldwin, Amelia Wiercioch
BACKGROUND AND OBJECTIVES: The potential for synthetic cannabinoids (SCs) to function as an alternative to marijuana without the same risk of a positive urinalyses led to claims of pervasive military SC use. Case studies confirm use among veterans, but no study has adequately explored SC use in the military using detailed interview data. METHODS: Interviews (1-2 h) were conducted with 318 justice-involved veterans. Recruitment was attempted with all participants in eight veterans treatment courts in three U...
March 28, 2024: Substance Use & Misuse
https://read.qxmd.com/read/38542886/chemistry-and-pharmacology-of-delta-8-tetrahydrocannabinol
#14
REVIEW
Maged S Abdel-Kader, Mohamed M Radwan, Ahmed M Metwaly, Ibrahim H Eissa, Arno Hazekamp, Mahmoud A ElSohly
Cannabis sativa is one of the oldest plants utilized by humans for both economic and medical purposes. Although the use of cannabis started millennia ago in the Eastern hemisphere, its use has moved and flourished in the Western nations in more recent centuries. C. sativa is the source of psychoactive cannabinoids that are consumed as recreational drugs worldwide. The C21 aromatic hydrocarbons are restricted in their natural occurrence to cannabis (with a few exceptions). Delta-9-tetrahydrocannabinol (Δ9 -THC) is the main psychoactive component in cannabis, with many pharmacological effects and various approved medical applications...
March 11, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38542177/beta-caryophyllene-a-cannabinoid-receptor-type-2-selective-agonist-in-emotional-and-cognitive-disorders
#15
REVIEW
Caterina Ricardi, Serena Barachini, Giorgio Consoli, Donatella Marazziti, Beatrice Polini, Grazia Chiellini
Mental disorders account for one of the most prevalent categories of the burden of disease worldwide, with depression expected to be the largest contributor by 2030, closely followed by anxiety. The COVID-19 pandemic possibly exacerbated these challenges, especially amongst adolescents, who experienced isolation, disrupted routines, and limited healthcare access. Notably, the pandemic has been associated with long-term neurological effects known as "long-COVID", characterized by both cognitive and psychopathological symptoms...
March 11, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38542057/timeframe-analysis-of-novel-synthetic-cannabinoids-effects-a-study-on-behavioral-response-and-endogenous-cannabinoids-disruption
#16
JOURNAL ARTICLE
Jorge Carlos Pineda Garcia, Ren-Shi Li, Ruri Kikura-Hanajiri, Yoshitaka Tanaka, Yuji Ishii
This study investigates the impact of SCs consumption by assessing the effects of three novel synthetic cannabinoids (SCs); MDMB-CHMINACA, 5F-ADB-PINACA, and APICA post-drug treatment. SCs are known for their rapid onset (<1 min) and prolonged duration (≥5 h). Therefore, this research aimed to assess behavioral responses and their correlation with endocannabinoids (ECs) accumulation in the hippocampus, and EC's metabolic enzymes alteration at different timeframes (1-3-5-h) following drug administration...
March 7, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38532552/an-lc-ms-ms-method-for-the-determination-of-drugs-of-abuse-included-thc-cooh-etg-and-nps-using-a-single-hair-extraction-sample
#17
JOURNAL ARTICLE
Valentina Longo, Giulia Stocchero, Manuela Lucchiari, Giovanni Michele Marchio, Flora Donini, Francesco Ingenito, Lucia Bertoldi, Lucia Pecoraro, Adriano Anesi, Donata Favretto
Hair analysis plays an important role in the determination of drugs of abuse in both forensic and clinical toxicology investigations. The analysis of different substances often requires the use of different sample preparation methods, thereby increasing the amount of hair sample and time required. In the present study, a fast method involving a combination of a single 25 mg hair extraction procedure and four liquid chromatography-tandem mass spectrometry methods using the same chromatographic phases and column was developed and validated...
March 26, 2024: Drug Testing and Analysis
https://read.qxmd.com/read/38529884/lc-ms-ms-analysis-of-11-nor-9-carboxy-hexahydrocannabinol-hhc-cooh-and-11-hydroxy-hexahydrocannabinol-hhc-oh-for-verification-of-hexahydrocannabinol-hhc-intake
#18
JOURNAL ARTICLE
Paul Pettersson-Pablo, Joakim Oxelbark
Natural and semi-synthetic cannabinoid analogs are getting increasing media attention for their recreative use as an alternative to traditional cannabis, in Sweden as well as internationally. To investigate an increasing number of urine samples incoming to our clinical laboratory that were screening positive, using a CEDIA THC-COOH immunoassay from ThermoFisher Scientific, but then testing negative using GC-MS based verification analysis, we developed an LC-MS/MS-method for verification of hexahydrocannabinol (HHC) and Δ8-tetrahydrocannabinol...
March 26, 2024: Scandinavian Journal of Clinical and Laboratory Investigation
https://read.qxmd.com/read/38513529/analysis-of-drug-impregnated-paper-samples-seized-in-english-prisons-between-2018-and-2020
#19
JOURNAL ARTICLE
Asena Avci Akca, Lewis Couchman, Anca Frinculescu, Atholl Johnston
Novel psychoactive substances (NPS) in the form of impregnated papers delivered to prisoners are of particular concern in prison settings, where they are commonly used by vaping. The purpose of this study was to create a qualitative method for identifying the various emerging NPS impregnated onto paper samples sent to prisoners. It helps to demonstrate that these findings can be used to predict drug prevalence and trends in prisons. Between 2018 and 2020, 1250 non-judicial paper samples seized from 12 English prisons were analysed to determine the NPSs being circulated...
March 19, 2024: Forensic Science International
https://read.qxmd.com/read/38505994/cardiotoxic-effects-of-common-and-emerging-drugs-role-of-cannabinoid-receptors
#20
JOURNAL ARTICLE
Yiming Bo, Xin Zhao, Liliang Li
Drug-induced cardiotoxicity has become one of the most common and detrimental health concerns, which causes significant loss to public health and drug resources. Cannabinoid receptors (CBRs) have recently achieved great attention for their vital roles in the regulation of heart health and disease, with mounting evidence linking CBRs with the pathogenesis and progression of drug-induced cardiotoxicity. This review aims to summarize fundamental characteristics of two well-documented CBRs (CB1R and CB2R) from aspects of molecular structure, signaling and their functions in cardiovascular physiology and pathophysiology...
March 20, 2024: Clinical Science (1979-)
keyword
keyword
50608
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.